The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
作者:Thomas B. Kjeldsen、František Hubálek、Tina M. Tagmose、Lone Pridal、Hanne H. F. Refsgaard、Trine Porsgaard、Sanne Gram-Nielsen、Lars Hovgaard、Henrik Valore、Martin Münzel、Claudia U. Hjørringgaard、Claus Bekker Jeppesen、Valentina Manfè、Thomas Hoeg-Jensen、Svend Ludvigsen、Peter Kresten Nielsen、Inger Lautrup-Larsen、Carsten E. Stidsen、Erik M. Wulff、Patrick W. Garibay、János T. Kodra、Erica Nishimura、Peter Madsen